06.09.2014 Views

Breakthrough 2013 (PDF) - Swansea University

Breakthrough 2013 (PDF) - Swansea University

Breakthrough 2013 (PDF) - Swansea University

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Breakthrough</strong><br />

<strong>Breakthrough</strong><br />

Cross-cutting themes<br />

and research<br />

Society’s most pressing challenges are not easily<br />

resolved by individual academic disciplines<br />

working in isolation. Research into diseases such<br />

as cancer is now as likely to involve engineers<br />

and physicists as it is medical experts.<br />

Confronting the realities of climate change requires the skills of<br />

lawyers, economists and social scientists as well as geographers and<br />

researchers in the arts and humanities can be found working on the<br />

regeneration of industrial landscapes alongside those in the physical<br />

sciences. Interdisciplinary research, where academics cross traditional<br />

discipline boundaries to pursue new ideas and engage in new<br />

thinking, is integral to <strong>Swansea</strong> <strong>University</strong>’s approach to delivering<br />

research that has genuine, global relevance and impact.<br />

In this regard <strong>Swansea</strong>’s research has been closely aligned to the<br />

RCUK designated priority areas, which encompass: living with<br />

environmental change; ageing; lifelong health and wellbeing; digital<br />

economy; nanoscience through engineering to application; and<br />

medical diagnostics and therapeutics.<br />

The <strong>University</strong>’s research is also aligned to the European Commission’s<br />

Framework 7 priorities which include: health; food; agriculture; fisheries<br />

and biotechnology; ICT; nanosciences; energy; environment (including<br />

climate change); transport (including aeronautics); socio-economic<br />

sciences and the humanities; space and security.<br />

Also, within Wales, the <strong>University</strong>’s research is mapped against the<br />

Welsh Government’s Science Strategy for Wales, which identifies three<br />

priority areas driving economic growth: life sciences and health; low<br />

carbon, energy and environment; and advanced engineering and<br />

materials. At <strong>Swansea</strong>, for instance, research addressing life sciences<br />

and health ranges from medical technology, diagnostics, immunity, and<br />

cell technologies to health informatics, genetics, and public health.<br />

Research into water safety and security, energy generation, ecology<br />

and environmental monitoring, plays to the low carbon, energy and<br />

environment theme, whilst the <strong>University</strong>’s world-class strengths in<br />

engineering are contributing to advanced engineering and materials,<br />

particularly through research into aerospace, advanced materials and<br />

composites.<br />

Research that tackles each of these regional, national and international<br />

priority themes is underway across the institution, and is evidenced in<br />

detail in the following pages. This research is often facilitated through<br />

major, cross-cutting centres and institutes that provide world-class<br />

facilities and internationally recognised research leadership.<br />

Centre for NanoHealth<br />

Early diagnosis and treatment of diseases such as cancer could prevent suffering, save lives,<br />

and reduce costs for health services. <strong>Swansea</strong> <strong>University</strong> is responding to this challenge<br />

through the Centre for NanoHealth (CNH), a £21.6 million initiative that draws together<br />

expertise from the Colleges of Medicine and Engineering, in partnership with industry and<br />

the Abertawe Bro Morgannwg <strong>University</strong> Health Board (ABMU).<br />

Based in a clinical and biomedical research environment, the<br />

Centre is a pioneering, integrated facility where novel devices and<br />

sensors can be designed, manufactured and evaluated. Such<br />

advances in nanotechnology, together with developments in<br />

biomarker discovery, have the potential to lead to the detection of<br />

the onset of disease at the earliest possible stage.<br />

A key area of research within CNH focuses on how nanoparticles<br />

interact with organic material. Whilst it is important to explore and<br />

understand the therapeutic effect, it is also essential to understand<br />

how nanoparticles interact with healthy cells. This is an area in<br />

which <strong>Swansea</strong> has taken a lead in partnership with The<br />

Methodist Hospital Research Institute, Texas, and which has<br />

led to the development of the field of Transport Oncophysics<br />

– the ability to develop and deliver therapeutics that are not<br />

just personalised to individual cancer patients, but to individual<br />

lesions in the patient.<br />

Nano-devices and nano-biosensors will enable health professionals<br />

to detect and measure biomarkers present in fluid or tissue samples at<br />

a level of sensitivity far beyond current detection methods. They will<br />

also allow for point-of-care testing in community clinics, GP surgeries,<br />

or in the home, and will be used in the growing area of companion<br />

diagnostics, where devices report to a patient’s clinician through<br />

new e-health systems.<br />

Directed by Professor Steve Conlan (College of Medicine) and<br />

Professor Steve Wilks (College of Science), the Centre is funded<br />

by the European Regional Development Fund through the Welsh<br />

European Funding Office, and engages with small businesses,<br />

other universities, international corporations and the NHS through<br />

collaborative research and development projects. The Centre<br />

also works closely with the <strong>University</strong>’s Multidisciplinary<br />

Nanotechnology Centre (College of Engineering) and the<br />

Institute of Life Science (College of Medicine).<br />

Projects undertaken by CNH have been funded by a range of<br />

organisations, including EPSRC, the Biotechnology and Biological<br />

Sciences Research Council (BBSRC), the Technology Strategy<br />

Board (including Knowledge Transfer Partnerships), the European<br />

Commission’s FP7 programme, the Welsh Government, and the<br />

National Institute for Health Research.<br />

<strong>Swansea</strong> is also leading an alliance of four institutions from<br />

Wales and Ireland in a £1 million Celtic Alliance for NanoHealth<br />

venture to pioneer the development of cutting-edge healthcare.<br />

The alliance, which includes the <strong>University</strong> College Dublin Centre<br />

for BioNano Interactions, Trinity College Dublin Institute of<br />

Molecular Medicines and Centre for Research on Adaptive<br />

Nanostructures and Nanodevices (CRANN), and Dublin City<br />

<strong>University</strong> Biomedical Diagnostics Institute and Nanobiophotonics<br />

and Imaging Centre, will help companies on either side of the<br />

Irish Sea stay at the forefront of innovation and growth in what<br />

is a fast developing and hugely influential healthcare sector.<br />

20<br />

21

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!